Metformin, sitagliptin, and liraglutide modulate serum retinol-binding protein-4 level and adipocytokine production in type 2 diabetes mellitus rat model.
Can J Physiol Pharmacol
; 96(12): 1226-1231, 2018 Dec.
Article
em En
| MEDLINE
| ID: mdl-30075088
ABSTRACT
Many adipocytokines correlate with obesity and insulin resistance. We examined the effects of metformin, sitagliptin, and liraglutide in diabetic rats. Group 1 control normal (CN) rats received oral saline daily. Group 2 diabetic non-treated (DNT) rats were injected with streptozotocin (STZ) to get diabetic then after 72 h received oral saline daily. Group 3 rats were injected with STZ then after 72 h were treated with metformin (200 mg/kg) orally. Group 4 rats were injected with STZ then after 72 h received sitagliptin 6 mg/kg orally twice daily. Group 5 rats were injected with STZ then after 72 h were treated with liraglutide at a dose of 0.3 mg/kg every 12 h subcutaneous injection. After 8 weeks, body mass, fasting blood glucose, adipocytokines, and lipid profile were assessed. From the results, we concluded that the 3 drugs improved blood glucose and insulin resistance with correction of adipocytokines serum levels; however, the liraglutide-treated group was the only group that showed significant body mass reduction.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Proteínas de Ligação ao Retinol
/
Diabetes Mellitus Tipo 2
/
Adipocinas
/
Fosfato de Sitagliptina
/
Liraglutida
/
Metformina
Limite:
Animals
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article